“The Effectiveness and Safety of Fenofibrate and Saroglitazar in the Treatment of Diabetic Dyslipidemia”. Life and Science, vol. 5, no. 2, May 2024, p. 07, https://doi.org/10.37185/LnS.1.1.632.